Australia, Feb. 25 -- Renibus Therapeutics Inc., owns the trademark (2506336) for 'ZIMTHRU' till June 5, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, pharmaceutical preparations for use in aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement.]
Type of Mark: Word
Date of Acceptance: Dec. 17, 2024
Registration Advertised: Feb. 24
For further details contact Brandon P. Leahy WILSON SONSINI GOODRICH & ROSATI.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2506336.
Disclaimer: Curated by HT Syndication.
